|
|
|
Volumn 10, Issue 7, 2007, Pages 463-467
|
|
Overcoming technical challenges in the development of cancer vaccines
|
|
Author keywords
Angiogenesis; Cancer vaccines; Inflammation; Multi modality combinations; T regulatory cells; Technical challenges; Tumor induced immune suppression
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
BCG VACCINE;
BEVACIZUMAB;
CANCER VACCINE;
CELECOXIB;
CYCLOOXYGENASE 2 INHIBITOR;
DECAY ACCELERATING FACTOR;
DOXYCYCLINE;
GANGLIOSIDE ANTIBODY;
GANGLIOSIDE GM2;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR VACCINE;
INTERLEUKIN 2 DERIVATIVE;
KEYHOLE LIMPET HEMOCYANIN;
LENALIDOMIDE;
MELACINE;
MYCOBACTERIUM VACCINE;
ONCOVAX;
PROVENGE;
QS 21;
RENIALE;
ROFECOXIB;
SORAFENIB;
SRL 172;
SUNITINIB;
TROVAX;
TUMOR ANTIGEN;
UNCLASSIFIED DRUG;
VITESPIN;
ADJUVANT THERAPY;
ANGIOGENESIS;
CANCER IMMUNOTHERAPY;
CLINICAL TRIAL;
COLORECTAL CARCINOMA;
DRUG EFFICACY;
DRUG WITHDRAWAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
IMMUNE RESPONSE;
KIDNEY CARCINOMA;
LOW DRUG DOSE;
MELANOMA;
NONHUMAN;
PROSTATE CANCER;
REVIEW;
SOLID TUMOR;
UNSPECIFIED SIDE EFFECT;
BIOTECHNOLOGY;
CANCER VACCINES;
CLINICAL TRIALS;
HUMANS;
NEOPLASMS;
|
|
EID: 34447622846
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (0)
|
